Vitiligo of the arm after COVID-19 vaccination

Vitiligo of the arm after COVID-19 vaccination

Bibliographic Details
Main Authors:	Rhea Singh, BS, Jay L. Cohen, MD, Michael Astudillo, MD, John E. Harris, MD, PhD, Esther E. Freeman, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2022-10-01
Series:	JAAD Case Reports
Subjects:	COVID-19 depigmentation SARS-CoV-2 vaccines vitiligo
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512622002582

Similar Items

Localized vitiligo occurring in an old biopsy scar: A case report
by: Kevin Rychik, BS, et al.
Published: (2020-04-01)

Assessment of Serum Copper Level among Sudanese Patients with vitiligo
by: Mehad Muawia, et al.
Published: (2020-03-01)

Prevalence of Vitiligo Among Patients in Baquba City
by: Mohammad Husain Al-Qayssi
Published: (2019-05-01)

Prevalence of Vitiligo Among Patients in Baquba City
by: Mohammad Husain Al-Qayssi
Published: (2019-05-01)

A clinico-epidemiological study on childhood vitiligo
by: Neerja Puri
Published: (2016-01-01)

Melanogenic effects of 5-demethylnobiletin on mouse model of chemical-induced vitiligo
by: Hui Miao Wang, et al.
Published: (2024-01-01)

Correlation of Dermatology Life Quality Index and Vitiligo Extent Tensity Index: A Cross-sectional Study
by: Naveen Netaji Rao, et al.
Published: (2022-12-01)

Depigmentation therapy with Q-switched Nd: YAG laser in universal vitiligo
by: Imran Majid, et al.
Published: (2013-01-01)

Microneedling in vitiligo: A systematic review
by: Masoumeh Roohaninasab, et al.
Published: (2022-12-01)

Monobenzyl ether of hydroquinone 20 and 40% cream in depigmentation of patients with vitiligo: a randomized controlled trial
by: Medhat El Mofty, et al.
Published: (2020-01-01)

Nivolumab induced vitiligo-like depigmentation in metastatic acral lentiginous melanoma
by: Disha Dabbas, et al.
Published: (2019-01-01)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023-06-01)

Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: vitiligo and the uveodermatological syndrome: a comprehensive review
by: Heng L. Tham, et al.
Published: (2019-07-01)

Possible role of psoralen-induced phototoxicity in the development of vitiligo
by: Genevieve Patrick, BS, et al.
Published: (2022-03-01)

Vitiligo following COVID-19: A case report and review of pathophysiology
by: Alexandra F. Schmidt, BS, et al.
Published: (2022-04-01)

Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001)
by: Lisa Liu, BS, et al.
Published: (2023-09-01)

Prurigo nodularis in vitiligo patches: An unusual observation
by: Karim Saleh, MD, PhD
Published: (2020-09-01)

Upadacitinib and its role in the treatment of vitiligo: A new possible therapeutic perspective
by: Jorge Magdaleno-Tapial, PhD, et al.
Published: (2024-04-01)

Carbamazepine-induced reversible vitiligo
by: Luai M. Assaedi, MD, et al.
Published: (2022-08-01)

Chronic spontaneous urticaria following COVID-19 vaccination
by: Laurence de Montjoye, MD, PhD, et al.
Published: (2022-07-01)

Eosinophilic fasciitis following SARS-CoV-2 vaccination
by: Victoria Lobo Antuña, MD, et al.
Published: (2023-06-01)

Vitiligo Vitiligo
by: Denise Steiner, et al.
Published: (2004-05-01)

Major cardiac concerns in therapy and vaccinations for COVID-19
by: Syam Sundar Junapudi, MD, et al.
Published: (2021-09-01)

Diagnostic findings in Various Cutaneous Hypopigmented Disorders: A Scoping Review
by: Sabiha Quazi, et al.
Published: (2024-03-01)

Case Report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data
by: Hui Rao, et al.
Published: (2023-01-01)

Associations of Temporal Cardiometabolic Patterns and Incident SARS-CoV-2 Infection Among U.S. Blood Donors With Serologic Evidence of Vaccination
by: Elaine A. Yu, PhD, et al.
Published: (2024-04-01)

Autoimmune response against tyrosinase induces depigmentation in C57BL/6 black mice
by: Ahmad A. Al Robaee, et al.
Published: (2020-12-01)

Vitiligo associated with polycaprolactone-based collagen stimulator filler
by: Chun-Hsien Huang, MD, et al.
Published: (2022-06-01)

Localized Vitiligo and Post-Inflammatory Hypopigmentation at the Injection Site of a COVID-19 mRNA Vaccine
by: Dora Mancha, et al.
Published: (2023-01-01)

Durvalumab-associated generalized morphea with overlapping vitiligo
by: Julianna Martel, MD, et al.
Published: (2022-12-01)

Terapia despigmentante para vitiligo generalizado com solução tópica de fenol 88% Depigmentation therapy for generalized vitiligo with topical 88% phenol solution
by: Maurício Zanini, et al.
Published: (2005-08-01)

A Case of Hypophysitis Associated With SARS-CoV-2 Vaccination
by: Anvitha R. Ankireddypalli, MD, et al.
Published: (2022-09-01)

Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo
by: Laura Macca, et al.
Published: (2022-09-01)

Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine
by: Giovanni Paolino, MD, PhD, et al.
Published: (2022-03-01)

Vitiligo, con énfasis en su variante inflamatoria Vitiligo, with emphasis in its inflammatory variant
by: C I Vera, et al.
Published: (2009-03-01)

Do not miss Bickerstaff encephalitis as a complication of SARS-CoV-2 vaccines
by: Josef Finsterer, MD, PhD, et al.
Published: (2022-08-01)

The concept of stability of vitiligo: A reappraisal
by: Koushik Lahiri, et al.
Published: (2012-01-01)

Relación entre vitíligo y Covid-19
by: Jeanneth Elizabeth Jami-Carrera, et al.
Published: (2023-12-01)

Vitiligo- A surgical approach
by: Deepti Ghia, et al.
Published: (2012-01-01)

Vitiligo na infância: características clínicas e epidemiológicas Childhood vitiligo: clinical and epidemiological characteristics
by: Cláudia Márcia de Resende Silva, et al.
Published: (2007-02-01)